Tsuchida, R.; Nishizawa, D.; Fukuda, K.-i.; Ichinohe, T.; Kano, K.; Kurano, M.; Ikeda, K.; Sumitani, M.
Genetic Polymorphisms of ENPP2 Are Possibly Associated with Pain Severity and Opioid Dose Requirements in Patients with Inflammatory Pain Conditions: Clinical Observation Study. Int. J. Mol. Sci. 2023, 24, 6986.
https://doi.org/10.3390/ijms24086986
AMA Style
Tsuchida R, Nishizawa D, Fukuda K-i, Ichinohe T, Kano K, Kurano M, Ikeda K, Sumitani M.
Genetic Polymorphisms of ENPP2 Are Possibly Associated with Pain Severity and Opioid Dose Requirements in Patients with Inflammatory Pain Conditions: Clinical Observation Study. International Journal of Molecular Sciences. 2023; 24(8):6986.
https://doi.org/10.3390/ijms24086986
Chicago/Turabian Style
Tsuchida, Rikuhei, Daisuke Nishizawa, Ken-ichi Fukuda, Tatsuya Ichinohe, Kuniyuki Kano, Makoto Kurano, Kazutaka Ikeda, and Masahiko Sumitani.
2023. "Genetic Polymorphisms of ENPP2 Are Possibly Associated with Pain Severity and Opioid Dose Requirements in Patients with Inflammatory Pain Conditions: Clinical Observation Study" International Journal of Molecular Sciences 24, no. 8: 6986.
https://doi.org/10.3390/ijms24086986
APA Style
Tsuchida, R., Nishizawa, D., Fukuda, K.-i., Ichinohe, T., Kano, K., Kurano, M., Ikeda, K., & Sumitani, M.
(2023). Genetic Polymorphisms of ENPP2 Are Possibly Associated with Pain Severity and Opioid Dose Requirements in Patients with Inflammatory Pain Conditions: Clinical Observation Study. International Journal of Molecular Sciences, 24(8), 6986.
https://doi.org/10.3390/ijms24086986
